Related Experiment Videos
Controversies in the prevention of deep vein thrombosis with total hip arthroplasty
1Department of Orthopedic Surgery, Wayne State University School of Medicine, Detroit, Mich.
Insights
Thromboembolic disease, a significant risk following hip and knee replacements, affects about one in six patients. Early hospital discharge contributes to this growing concern, leading to numerous deaths annually.
Area of Science:
- Orthopedic Surgery
- Vascular Medicine
- Patient Safety
Background:
- Thromboembolic disease poses a significant health risk, particularly for patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA).
- Increasingly early hospital discharge for THA and TKA patients, as early as postoperative day four, is a contributing factor to the rising incidence of this condition.
- An estimated 50,000 deaths annually in the United States are linked to thromboembolic disease, with similar prevalence in other developed nations like Great Britain.
Purpose of the Study:
- To highlight the growing problem of thromboembolic disease in joint replacement surgery.
- To underscore the association between early postoperative discharge and the incidence of thromboembolic events.
- To emphasize the asymptomatic nature of the condition in most patients, making early detection challenging.
Main Methods:
- Review of current clinical practices and patient outcomes in THA and TKA.
- Analysis of epidemiological data on thromboembolic disease incidence and mortality post-joint replacement.
- Comparison of complication rates in relation to hospital discharge timing.
Main Results:
- Thromboembolic disease is a common complication following THA and TKA, affecting approximately one in six patients.
- Early discharge protocols are associated with an increased risk of developing thromboembolic complications.
- The majority of patients with thromboembolic disease following joint replacement remain asymptomatic.
Conclusions:
- Thromboembolic disease represents a critical and escalating issue in the context of modern joint replacement surgery.
- Current early discharge practices necessitate a re-evaluation to mitigate the risk of preventable thromboembolic events.
- Enhanced surveillance and preventative strategies are crucial for patients undergoing THA and TKA, given the high incidence and asymptomatic presentation of thromboembolic disease.
Abstract:
Thromboembolic disease is a serious problem that is growing because both total hip arthroplasty (THA) and total knee arthroplasty (TKA) patients are now being discharged from the hospital as early as the fourth postoperative day. The current estimate is that 50,000 deaths a year in the United States can be attributed to this disease process, and it is an equally large problem in other countries such as Great Britain (Table 1). Thromboembolic disease is asymptomatic in the vast majority of patients undergoing joint replacement. Approximately one in six patients develops the condition following THA or TKA.